Details of the Drug

General Information of Drug (ID: DMQKFWX)

Drug Name
Pegargiminase
Synonyms ADI-PEG-20
Indication
Disease Entry ICD 11 Status REF
Hepatocellular carcinoma 2C12.02 Phase 3 [1]
Mesothelioma 2C51.2 Phase 2/3 [2]
Melanoma 2C30 Phase 2 [3]
Gastrointestinal cancer 2C11 Phase 1/2 [2]
Argininosuccinate synthase deficiency 5C50.A3 Phase 1 [2]
Solid tumour/cancer 2A00-2F9Z Phase 1 [2]
⏷ Show the Full List of Indication(s)
Drug Type
Recombinant protein
Cross-matching ID
PubChem CID
14497139
UNII
0B7PYQ9YRT
DrugBank ID
DB06592
TTD ID
D0KB0Y
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

References

1 Clinical pipeline report, company report or official report of Polaris Pharmaceuticals.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)